Zhao‐you Tang

Zhao‐you Tang's AcademicInfluence.com Rankings

Zhao‐you Tang

Philosophy

#8194

World Rank

#11527

Historical Rank

Logic

#5221

World Rank

#6604

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Zhao‐you Tang's Degrees

PhD Medicine Fudan University

Why Is Zhao‐you Tang Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Zhao‐you Tang's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Randomized controlled trial of screening for hepatocellular carcinoma (2004) (1296)
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. (2009) (1092)
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. (2007) (1047)
Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning (2003) (816)
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. (2006) (782)
A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. (2010) (755)
Identification of metastasis‐related microRNAs in hepatocellular carcinoma (2008) (726)
EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. (2008) (687)
MicroRNA expression, survival, and response to interferon in liver cancer. (2009) (643)
Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. (2011) (546)
Identification of microRNA‐181 by genome‐wide screening as a critical player in EpCAM–positive hepatic cancer stem cells (2009) (530)
High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. (2008) (505)
p53 mutation in hepatocellular carcinoma after aflatoxin exposure (1991) (478)
A decade’s studies on metastasis of hepatocellular carcinoma (2004) (426)
Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects (2010) (321)
The prognostic molecular markers in hepatocellular carcinoma. (2002) (319)
Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival. (2012) (290)
Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma (2001) (280)
Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics (2004) (210)
Gene Expression Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma (2007) (210)
Transcriptomic profiling reveals hepatic stem‐like gene signatures and interplay of miR‐200c and epithelial‐mesenchymal transition in intrahepatic cholangiocarcinoma (2012) (206)
Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature (2004) (204)
Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. (2010) (201)
Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes. (2013) (184)
Postoperative interferon α treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial (2006) (183)
Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma (2017) (180)
Human Hepatocellular Carcinoma Tumor–derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial Cells (2009) (180)
Heat‐shock protein 27: A potential biomarker for hepatocellular carcinoma identified by serum proteome analysis (2005) (176)
The prognostic significance of clinical and pathological features in hepatocellular carcinoma. (2002) (172)
From Proteomic Analysis to Clinical Significance (2004) (167)
Clinical evaluation of cryosurgery in the treatment of primary liver cancer Report of 60 Cases (1988) (166)
A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus. (2005) (166)
Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. (2007) (163)
Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer. (2006) (163)
Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues (1996) (160)
Proteome analysis of hepatocellular carcinoma cell strains, MHCC97‐H and MHCC97‐L, with different metastasis potentials (2004) (150)
Effect of Rapamycin Alone and in Combination with Sorafenib in an Orthotopic Model of Human Hepatocellular Carcinoma (2008) (145)
GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis. (2016) (144)
Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial. (2006) (143)
Activation of β-Catenin by Hypoxia in Hepatocellular Carcinoma Contributes to Enhanced Metastatic Potential and Poor Prognosis (2010) (142)
miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a (2018) (139)
The biocompatibility of quantum dot probes used for the targeted imaging of hepatocellular carcinoma metastasis. (2008) (139)
Cytokeratin 10 and Cytokeratin 19: Predictive Markers for Poor Prognosis in Hepatocellular Carcinoma Patients after Curative Resection (2008) (139)
Inhibition of Growth and Metastasis of Human Hepatocellular Carcinoma by Antisense Oligonucleotide Targeting Signal Transducer and Activator of Transcription 3 (2006) (138)
Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial–Mesenchymal Transition (2011) (133)
Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study (2018) (131)
Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection. (2009) (129)
Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma. (2011) (125)
High‐lose and long‐term therapy with interferon‐alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential (2000) (122)
Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis. (2003) (120)
Hepatocellular carcinoma: insight from animal models (2012) (111)
Microvessel density of hepatocellular carcinoma: its relationship with prognosis (1999) (110)
Evaluation of Midkine as a Diagnostic Serum Biomarker in Hepatocellular Carcinoma (2013) (109)
Wnt signaling in hepatocellular carcinoma: Analysis of mutation and expression of beta‐catenin, T‐cell factor‐4 and glycogen synthase kinase 3‐beta genes (2003) (107)
MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2 (2016) (107)
Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy (2009) (106)
MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression. (2013) (104)
MicroRNA-26a Inhibits Angiogenesis by Down-Regulating VEGFA through the PIK3C2α/Akt/HIF-1α Pathway in Hepatocellular Carcinoma (2013) (101)
Dendritic cell infiltration and prognosis of human hepatocellular carcinoma (2006) (100)
Gene Expression Profiling of Fixed Tissues Identified Hypoxia-Inducible Factor-1α, VEGF, and Matrix Metalloproteinase-2 as Biomarkers of Lymph Node Metastasis in Hepatocellular Carcinoma (2011) (100)
Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival (2009) (97)
Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives (2004) (92)
A Comparison of Chemoembolization Combination With and Without Radiotherapy for Unresectable Hepatocellular Carcinoma (2004) (92)
The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma (2006) (89)
Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study. (2004) (87)
HIWI is associated with prognosis in patients with hepatocellular carcinoma after curative resection (2012) (86)
The Clinical Significance of the CD163+ and CD68+ Macrophages in Patients with Hepatocellular Carcinoma (2013) (86)
Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients. (2005) (85)
Diagnosis and treatment of hepatic angiomyolipoma in 26 cases. (2003) (85)
Overexpression of Platelet-Derived Growth Factor Receptor α in Endothelial Cells of Hepatocellular Carcinoma Associated with High Metastatic Potential (2005) (84)
Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy (2007) (84)
Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice. (2012) (81)
Modulation of miR‐29 expression by alpha‐fetoprotein is linked to the hepatocellular carcinoma epigenome (2014) (78)
Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma (2009) (78)
High expression of Dickkopf‐related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery (2013) (78)
Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus (2000) (75)
Invasion and metastasis of liver cancer: expression of intercellular adhesion molecule 1 (1999) (75)
Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor (2008) (74)
Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice (2003) (72)
Hepatocellular carcinoma surgery–review of the past and prospects for the 21st century (2005) (71)
The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs) (2012) (70)
Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma. (2017) (70)
Consideration of the Role of Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Retrospective Analysis of 75 Patients (2006) (69)
MiR-302c inhibits tumor growth of hepatocellular carcinoma by suppressing the endothelial-mesenchymal transition of endothelial cells (2014) (69)
The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma (2006) (69)
Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection (2014) (67)
Elevated activity of N -acetylglucosaminyltransferase V in human hepatocellular carcinoma (1998) (66)
Combination of peritumoral mast cells and T‐regulatory cells predicts prognosis of hepatocellular carcinoma (2009) (66)
Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis. (2005) (65)
Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients (2010) (65)
Radiation therapy for adrenal gland metastases from hepatocellular carcinoma. (2005) (65)
Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience. (2006) (64)
Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation (2009) (63)
Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection. (2008) (63)
Improved Survival with Resectionafter Transcatheter ArterialChemoembolization (TACE) for Unresectable Hepatocellular Carcinoma (1998) (62)
Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues (2006) (62)
Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Unresectable Hepatitis B Virus-related Hepatocellular Carcinoma: A Single Center Study of 45 Patients. (2020) (61)
Intratumoral α-SMA Enhances the Prognostic Potency of CD34 Associated with Maintenance of Microvessel Integrity in Hepatocellular Carcinoma and Pancreatic Cancer (2013) (60)
P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection. (2002) (60)
Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations (2021) (58)
High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resection. (2010) (58)
Interferon alpha 2a downregulates VEGF expression through PI3 kinase and MAP kinase signaling pathways (2005) (57)
Chromosome instability in human hepatocellular carcinoma depends on p53 status and aflatoxin exposure. (2008) (56)
Preventive treatments for recurrence after curative resection of hepatocellular carcinoma--a literature review of randomized control trials. (2003) (55)
Incomplete Radiofrequency Ablation Enhances Invasiveness and Metastasis of Residual Cancer of Hepatocellular Carcinoma Cell HCCLM3 via Activating β-Catenin Signaling (2014) (54)
Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma (2009) (53)
Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin (2010) (52)
Suppression of Natural Killer Cells by Sorafenib Contributes to Prometastatic Effects in Hepatocellular Carcinoma (2013) (52)
Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma (2001) (52)
Identification and analysis of altered α1,6‐fucosylated glycoproteins associated with hepatocellular carcinoma metastasis (2006) (52)
Plasma hsa_circ_0027089 is a diagnostic biomarker for hepatitis B virus-related hepatocellular carcinoma (2019) (51)
Increased Expression of Vascular Endothelial Growth Factor-C and Nuclear CXCR4 in Hepatocellular Carcinoma Is Correlated With Lymph Node Metastasis and Poor Outcome (2009) (51)
CircRNA-100338 Is Associated With mTOR Signaling Pathway and Poor Prognosis in Hepatocellular Carcinoma (2019) (51)
P48 is a predictive marker for outcome of postoperative interferon‐α treatment in patients with hepatitis B virus infection‐related hepatocellular carcinoma (2006) (51)
Diagnosis and surgical treatments of hepatocellular carcinoma with tumor thrombosis in bile duct: experience of 34 patients. (2004) (50)
Identification of MSRA gene on chromosome 8p as a candidate metastasis suppressor for human hepatitis B virus-positive hepatocellular carcinoma (2007) (50)
Influence of hepatic artery occlusion on tumor growth and metastatic potential in a human orthotopic hepatoma nude mouse model: Relevance of epithelial–mesenchymal transition (2010) (50)
Downregulation of CCR1 inhibits human hepatocellular carcinoma cell invasion. (2007) (48)
Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection (2010) (48)
Integrative Genomics Identifies YY1AP1 as an Oncogenic Driver in EpCAM+ AFP+ Hepatocellular Carcinoma (2014) (47)
Circulating DNA level is negatively associated with the long-term survival of hepatocellular carcinoma patients. (2006) (47)
Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external‐beam radiation therapy (2008) (46)
Allelic imbalance regions on chromosomes 8p, 17p and 19p related to metastasis of hepatocellular carcinoma: comparison between matched primary and metastatic lesions in 22 patients by genome-wide microsatellite analysis (2003) (45)
Surgery for large primary liver cancer more than 10 cm in diameter (2003) (45)
Basement membrane proteins play an active role in the invasive process of human hepatocellular carcinoma cells with high metastasis potential (2005) (44)
Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization (2012) (44)
First in-human intraoperative imaging of HCC using the fluorescence goggle system and transarterial delivery of near-infrared fluorescent imaging agent: a pilot study. (2013) (43)
Arsenic trioxide induces differentiation of CD133+ hepatocellular carcinoma cells and prolongs posthepatectomy survival by targeting GLI1 expression in a mouse model (2014) (42)
The expression of HIF-1α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome (2012) (42)
Benefit of radiotherapy for 90 patients with resected intrahepatic cholangiocarcinoma and concurrent lymph node metastases (2010) (42)
Aspirin Minimized the Pro-Metastasis Effect of Sorafenib and Improved Survival by Up-Regulating HTATIP2 in Hepatocellular Carcinoma (2013) (41)
Experimental models of hepatocellular carcinoma: developments and evolution (2009) (41)
Risk factors for postoperative complications after liver resection. (2005) (40)
A comparison of hepatic mucinous cystic neoplasms with biliary intraductal papillary neoplasms. (2009) (40)
Targeting angiogenesis for liver cancer: Past, present, and future (2020) (40)
Potential prognostic biomarkers for bone metastasis from hepatocellular carcinoma. (2011) (39)
Focal nodular hyperplasia of the liver in 86 patients. (2007) (39)
Hepatic angiomyolipoma: A retrospective study of 25 cases (2008) (39)
Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway. (2017) (38)
From Proteomic Analysis to Clinical Significance OVEREXPRESSION OF CYTOKERATIN 19 CORRELATES WITH HEPATOCELLULAR CARCINOMA METASTASIS* (2004) (38)
Clinical Experience with Primary Hepatic Epithelioid Hemangioendothelioma: Retrospective Study of 33 Patients (2012) (38)
Biological characteristics of fluorescent protein-expressing human hepatocellular carcinoma xenograft model in nude mice (2008) (37)
Low Level of Low-Density Lipoprotein Receptor-Related Protein 1 Predicts an Unfavorable Prognosis of Hepatocellular Carcinoma after Curative Resection (2012) (37)
Integrative Genomic and Transcriptomic Characterization of Matched Primary and Metastatic Liver and Colorectal Carcinoma (2015) (37)
Expression of the integrinα5 subunit and its mediated cell adhesion in hepatocellular carcinoma (2005) (37)
Iodized oil enhances the thermal effect of high-intensity focused ultrasound on ablating experimental liver cancer (1997) (36)
Radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma with reference to second‐look resection (1990) (36)
Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma (2011) (36)
Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins (2004) (35)
Prediction of chronic hepatitis B, liver cirrhosis and hepatocellular carcinoma by SELDI-based serum decision tree classification (2007) (34)
An immune function assay predicts post-transplant recurrence in patients with hepatocellular carcinoma (2011) (34)
Aryl hydrocarbon receptor nuclear translocator is associated with tumor growth and progression of hepatocellular carcinoma (2012) (34)
Identification of N-glycan of alpha-fetoprotein by lectin affinity microarray (2008) (34)
Down-regulation of CXCR7 inhibits the growth and lung metastasis of human hepatocellular carcinoma cells with highly metastatic potential. (2012) (34)
Impact factors for microinvasion in patients with hepatocellular carcinoma: possible application to the definition of clinical tumor volume. (2010) (33)
Expression and prognostic significance of placental growth factor in hepatocellular carcinoma and peritumoral liver tissue (2011) (33)
The expression of the mdm2 gene may be related to the aberration of the p53 gene in human hepatocellular carcinoma (1998) (32)
Herbal extract “Songyou Yin” inhibits tumor growth and prolongs survival in nude mice bearing human hepatocellular carcinoma xenograft with high metastatic potential (2009) (32)
Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival (2009) (31)
Expressed proteome analysis of human hepatocellular carcinoma in nude mice (LCI‐D20) with high metastasis potential (2006) (31)
Mutation and overexpression of the β-catenin gene may play an important role in primary hepatocellular carcinoma among Chinese people (2001) (30)
High-intensity focused ultrasound in the treatment of experimental liver tumour (2005) (30)
The role of cryosurgery in the treatment of hepatic cancer: a report of 113 cases (2005) (29)
Insufficient Radiofrequency Ablation Treated Hepatocellular Carcinoma Cells Promote Metastasis by Up-Regulation ITGB3 (2017) (28)
Antiangiogenic therapy promoted metastasis of hepatocellular carcinoma by suppressing host-derived interleukin-12b in mouse models (2013) (28)
Cytoreduction and sequential resection: A hope for unresectable primary liver cancer (1991) (28)
Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma. (2000) (28)
Truncated Hepatitis B Virus RNA in Human Hepatocellular Carcinoma: Its Representation in Patients with Advancing Age (1999) (28)
A three-dimensional cell biology model of human hepatocellular carcinoma in vitro (2011) (27)
Downstaging followed by resection plays a role in improving prognosis of unresectable hepatocellular carcinoma. (2004) (27)
Preliminary result of mixed bacterial vaccine as adjuvant treatment of hepatocellular carcinoma (1991) (27)
Flot2 promotes tumor growth and metastasis through modulating cell cycle and inducing epithelial-mesenchymal transition of hepatocellular carcinoma. (2017) (26)
Cytoreduction and sequential resection for surgically verified unresectable hepatocellular carcinoma: Evaluation with analysis of 72 patients (1995) (26)
Development of a miR-26 Companion Diagnostic Test for Adjuvant Interferon-alpha Therapy in Hepatocellular Carcinoma (2013) (26)
Comparison between radioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma (2002) (26)
Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases. (2006) (26)
Expression of cytokeratin 19 and matrix metalloproteinase 2 predicts lymph node metastasis in hepatocellular carcinoma (2011) (25)
Improved long-term survival for unresectable hepatocellular carcinoma (HCC) with a combination of surgery and intrahepatic arterial infusion of 131I-anti-HCC mAb. Phase I/II clinical trials (1998) (25)
Prognostic Roles of Cross-Talk between Peritumoral Hepatocytes and Stromal Cells in Hepatocellular Carcinoma Involving Peritumoral VEGF-C, VEGFR-1 and VEGFR-3 (2013) (25)
Loss of Heterozygosity at D8S298 Is a Predictor for Long-term Survival of Patients with Tumor-Node-Metastasis Stage I of Hepatocellular Carcinoma (2007) (25)
A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice (2011) (25)
Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography (2011) (25)
Relationship between expression of α-fetoprotein messenger RNA and some clinical parameters of human hepatocellular carcinoma (1999) (24)
Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells. (2010) (24)
Serum CYFRA 21-1 level reflects hepatocellular carcinoma metastasis: study in nude mice model and clinical patients (2006) (24)
A novel peptide that selectively binds highly metastatic hepatocellular carcinoma cell surface is related to invasion and metastasis. (2007) (24)
Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma (2016) (24)
PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma (2021) (24)
MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma (2016) (23)
Abdominal drainage was unnecessary after hepatectomy using the conventional clamp crushing technique (2006) (23)
The prognostic factor for outcome following second resection for intrahepatic recurrence of hepatocellular carcinoma with a hepatitis B virus infection background (2005) (23)
A microRNA-based prediction model for lymph node metastasis in hepatocellular carcinoma (2015) (23)
Transmembrane receptor CXCR7 increases the risk of extrahepatic metastasis of relatively well-differentiated hepatocellular carcinoma through upregulation of osteopontin. (2013) (23)
Expression of connective tissue growth factor and interleukin-11 in intratumoral tissue is associated with poor survival after curative resection of hepatocellular carcinoma (2012) (22)
Intrahepatic splenosis mimicking hepatoma (2009) (22)
Prevention of hepatocellular carcinoma in mice by IL-2 and B7-1 genes co-transfected liver cancer cell vaccines. (2003) (21)
Metadherin–PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT–β-catenin signaling pathway (2019) (21)
Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinoma (2005) (21)
Study of angiogenesis induced by metastatic and non-metastatic liver cancer by corneal micropocket model in nude mice. (1999) (20)
NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma (2020) (20)
Metastatic models of human liver cancer in nude mice orthotopically constructed by using histologically intact patient specimens (2005) (20)
[Influence of tumor characteristics on the outcome of liver transplantation among patients with hepatocellular carcinoma]. (2007) (19)
The Rho GTPase Rnd1 inhibits epithelial–mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target (2018) (19)
The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib (2014) (19)
MAGE-1 and related MAGE gene expression may be associated with hepatocellular carcinoma (1999) (19)
Preoperative serum retinol-binding protein 4 is associated with the prognosis of patients with hepatocellular carcinoma after curative resection (2011) (19)
Capecitabine inhibits postoperative recurrence and metastasis after liver cancer resection in nude mice with relation to the expression of platelet-derived endothelial cell growth factor. (2003) (19)
Screening and detection of portal vein tumor thrombi-associated serum low molecular weight protein biomarkers in human hepatocellular carcinoma (2008) (19)
Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice (2011) (18)
Molecular cytogenetic characteristics of the human hepatocellular carcinoma cell line HCCLM3 with high metastatic potential: comparative genomic hybridization and multiplex fluorescence in situ hybridization. (2005) (18)
Contributions of lung tissue extracts to invasion and migration of human hepatocellular carcinoma cells with various metastatic potentials (2003) (18)
[Indication of liver transplantation for hepatocellular carcinoma: Shanghai Fudan Criteria]. (2006) (18)
Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China. (2005) (18)
Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma (2016) (17)
Small hepatocellular carcinoma: current status and prospects. (2002) (17)
Shanghai Score: A Prognostic and Adjuvant Treatment-evaluating System Constructed for Chinese Patients with Hepatocellular Carcinoma after Curative Resection (2017) (17)
KIAA0008 gene is associated with invasive phenotype of human hepatocellular carcinoma—a functional analysis (2004) (17)
Radiation therapy for the locoregional lymph node metastases from hepatocellular carcinoma, phase I clinical trial. (2004) (17)
Screening serum hepatocellular carcinoma-associated proteins by SELDI-based protein spectrum analysis. (2008) (17)
Abstract 5183: Modulation of miR-29 expression by alpha-fetoprotein is linked to the hepatocellular carcinoma epigenome (2014) (17)
Salvage transhepatic arterial embolization after failed stage I ALPPS in a patient with a huge HCC with chronic liver disease: A case report (2017) (16)
Transcriptome integration analysis in hepatocellular carcinoma reveals discordant intronic miRNA-host gene pairs in expression (2017) (16)
Twenty-year survivors after resection for hepatocellular carcinoma-analysis of 53 cases (2009) (16)
Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation (2011) (16)
Changed clinical aspects of primary liver cancer in China during the past 30 years. (2004) (16)
Reduction in p48-ISGFγ Levels Confers Resistance to Interferon-α2a in MHCC97 Cells (2005) (15)
Surgical Treatment of Subclinical Cases of Hepatocellular Carcinoma (1987) (15)
Atypical hepatic focal nodular hyperplasia presenting as acute abdomen and misdiagnosed as hepatocellular carcinoma (2007) (15)
Down-regulation of β-centractin might be involved in dendritic cells dysfunction and subsequent hepatocellular carcinoma immune escape: a proteomic study (2007) (15)
[Relationship between DLC-1 expressions and metastasis in hepatocellular carcinoma]. (2005) (15)
Treatment of unresectable primary liver cancer: With reference to cytoreduction and sequential resection (2004) (15)
A clinicopathological model to predict bone metastasis in hepatocellular carcinoma (2011) (15)
Solitary minute hepatocellular carcinoma. A study of 14 patients (1991) (15)
The potential of plasma thrombomodulin as a biomarker of portal vein tumor thrombus in hepatocellular carcinoma (2001) (15)
[Establishment of human hepatocellular carcinoma cell line with spontaneous pulmonary metastasis through in vivo selection]. (2002) (15)
CXCR7 correlates with the differentiation of hepatocellular carcinoma and suppresses HNF4α expression through the ERK pathway. (2014) (15)
Herbal compound "Songyou Yin" reinforced the ability of interferon-alfa to inhibit the enhanced metastatic potential induced by palliative resection of hepatocellular carcinoma in nude mice (2010) (15)
Bevacizumab enhances chemosensitivity of hepatocellular carcinoma to adriamycin related to inhibition of survivin expression (2011) (15)
Impact factors for microinvasion in intrahepatic cholangiocarcinoma: a possible system for defining clinical target volume. (2010) (14)
Direct Transformation of Lung Microenvironment by Interferon-α Treatment Counteracts Growth of Lung Metastasis of Hepatocellular Carcinoma (2013) (14)
Interferon-alpha 2a up-regulated thymidine phosphorylase and enhanced antitumor effect of capecitabine on hepatocellular carcinoma in nude mice (2004) (13)
Hepatocellular carcinoma associated with tumor thrombosis in the portal vein: the effects of different treatments. (2003) (13)
[Changes of clinical aspect of primary liver cancer in China during the past 30 years--control study for 3,250 cases with primary liver cancer]. (2003) (13)
Clinical research of hepatocellular carcinoma in the 21st Century (1995) (13)
Apoptosis of human BEL-7402 hepatocellular carcinoma cells released by antisense H-ras DNA-in vitro and in vivo studies (2005) (13)
Effects of cryopreservation and phenylacetate on biological characters of adherent LAK cells from patients with hepatocellular carcinoma. (2002) (12)
Radioimmunotherapy for unresectable hepatocellular carcinoma using131I-Hepama-1 mAb: preliminary results (2005) (12)
Long-term interferon-α treatment suppresses tumor growth but promotes metastasis capacity in hepatocellular carcinoma (2010) (12)
The value of postoperative hepatic regional chemotherapy in prevention of recurrence after radical resection of primary liver cancer. (2000) (12)
Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolization (2019) (12)
[Microsatellite alterations of circulating DNA in the plasma of patients with hepatocellular carcinoma]. (2006) (12)
Prediction of the Lymph Node Status in Patients with Intrahepatic Cholangiocarcinoma: Analysis of 320 Surgical Cases (2011) (12)
Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma. (2003) (12)
Up-regulation of platelet-derived growth factor-A is responsible for the failure of re-initiated interferon alpha treatment in hepatocellular carcinoma (2012) (12)
Radioiodinated anti-hepatocellular carcinoma (HCC) ferritin Targeting therapy, tumor imaging and anti-antibody response in HCC patients with hepatic arterial infusion (1992) (11)
Spatial localization of the JAG1/Notch1/osteopontin cascade modulates extrahepatic metastasis in hepatocellular carcinoma. (2014) (11)
[Nuclear accumulation of CXCR4 and overexpressions of VEGF-C and CK19 are associated with a higher risk of lymph node metastasis in hepatocellular carcinoma]. (2010) (11)
Intrahepatic and intraperitoneal splenosis mimicking hepatocellular carcinoma with abdominal wall metastasis in a patient with hepatitis C cirrhotic liver. (2015) (10)
Transcriptome and proteome of human hepatocellular carcinoma reveal shared metastatic pathways with significant genes (2015) (10)
Results of liver resection for primary liver cancer (1994) (10)
Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a (2018) (10)
The targeted expression of the human interleukin-2/interferon α2b fused gene in α-fetoprotein-expressing hepatocellular carcinoma cells (1999) (10)
Intrahepatic arterial I131 anti-hepatocellular carcinoma (HCC) monoclonal antibody combined with hepatic artery ligation for treatment of unresectable HCC (1993) (9)
Relationship between expression of alpha-fetoprotein messenger RNA and some clinical parameters of human hepatocellular carcinoma. (1999) (9)
Recurrence after resection ofα-fetoprotein-positive hepatocellular carcinoma (2005) (9)
Hepatocellular carcinoma with situs inversus totalis and polysplenia syndrome (2007) (9)
Hepatocellular Carcinoma: The Role of Screening. (2000) (9)
Efficacy of intra-hepatectomy 5-FU on recurrence and metastasis of human hepatocellular carcinoma in nude mice. (2001) (8)
The abnormalities of chromosome 8 in two hepatocellular carcinoma cell clones with the same genetic background and different metastatic potential (2003) (8)
Postoperative α-fetoprotein response predicts tumor recurrence and survival after hepatectomy for hepatocellular carcinoma: A propensity score matching analysis. (2019) (8)
Loss of heterozygosity at D14S62 and D14S51 detected by a simple and non-radioactive method in plasma DNA is a potential marker of metastasis and recurrence after curative hepatic resection in hepatocellular carcinoma. (2003) (8)
Multimodality treatment of hepatocellular carcinoma (1998) (7)
Analysis of the cellular origin of hepatocellular carcinoma by p53 genotype (2005) (7)
Phase I Clinical Trial of Oral Furtulon and Combined Hepatic Arterial Chemoembolization and Radiotherapy in Unresectable Primary Liver Cancers, Including Clinicopathologic Study (2000) (7)
Establishment of green fluorescent protein-expressing hepatocellular carcinoma cell lines with different metastatic potential: relevant models for in vivo monitoring of metastasis and angiogenesis (2004) (7)
Liver resection for early hepatocellular cancer: Comparison of centers in 3 different countries (2016) (6)
Higher intratumor than peritumor expression of DUSP6/MKP‐3 is associated with recurrence after curative resection of hepatocellular carcinoma (2014) (6)
Treatment of Hepatocellular Carcinoma (1998) (6)
[Relationship between dendritic cells and memory T lymphocytes in tumor site and prognosis of hepatocellular carcinoma]. (2005) (6)
[Loss of heterozygosity of plasma circulating DNA from hepatocellular carcinoma patients and its clinical significance]. (2007) (6)
Advances in Brief The Association of Chromosome 8 p Deletion and Tumor Metastasis in Human Hepatocellular Carcinoma 1 (1999) (6)
[Different expressions of chemokine receptors in human hepatocellular carcinoma cell lines with different metastatic potentials]. (2007) (6)
The antiangiogenic effects of tyroservatide on animal models of hepatocellular carcinoma (2009) (5)
Renin-angiotensin inhibitors were associated with improving outcomes of hepatocellular carcinoma with primary hypertension after hepatectomy. (2019) (5)
[The effects of portal vein microscopic and macroscopic tumor thrombi on post-operation patients with hepatocellular carcinoma]. (2005) (5)
Reduction in p48-ISGFgamma levels confers resistance to interferon-alpha2a in MHCC97 cells. (2004) (5)
Elevated MTSS 1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma (2016) (5)
[Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice]. (2006) (5)
Prognostic nomograms and risk classifications of outcomes in very early-stage hepatocellular carcinoma patients after hepatectomy. (2020) (5)
Cryohepatectomy for hepatocellular carcinoma--results in 84 patients. (2002) (4)
Human anti-(murine Ig) antibody responses in patients with hepatocellular carcinoma receiving intrahepatic arterial131I-labeled Hepama-1 mAb. Preliminary results and discussion (1994) (4)
Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinoma (2021) (4)
[In-vivo targeted imaging of hepatocellular carcinoma in nude mice using quantum dot probes]. (2007) (4)
5-fluorouracil and hydroxyurea enhance adenovirus-mediated transgene expression in colon and hepatocellular carcinoma cells (2005) (4)
Tumor radioimmunoimaging of chimeric antibody in nude mice with hepatoma xenograft. (1998) (4)
Transcatheter arterial embolization-salvaged ALPPS, a novel ALPPS procedure especially for patients with hepatocellular carcinoma and severe fibrosis/cirrhosis (2021) (4)
Simulation of portal/hepatic vein associated remnant liver ischemia/congestion by three-dimensional visualization technology based on preoperative CT scan (2021) (3)
Primary clear cell carcinoma of the liver (2012) (3)
The HBx protein expression in liver cancer (1993) (3)
[Three-grade criteria of curative resection for primary liver cancer]. (2004) (3)
Characteristics and prognosis of primary liver cancer in young patients in China (1995) (3)
[Study on the inhibitory effect of small tripeptide CMS024 on tumor growth and metastasis in nude mice model of human hepatocellular carcinoma metastasis]. (2004) (3)
Long-Term Survival of Hepatocellular Carcinoma with Reference to the Role of Early Resection, Multioperation and Multimodality Treatment (1986) (3)
[The prognostic significance of preoperative plasma level of osteopontin in combination with intercellular adhesion molecule-1 for patients with hepatocellular carcinoma]. (2005) (3)
Liver transplantation: A simple inflammation marker predicts liver cancer prognosis (2011) (3)
[Effects of MIM-B gene on invasive and metastatic potentials of human hepatocellular carcinoma MHCC97H cells]. (2010) (2)
[Vasoinhibitory effect of daltepartin sodium on human hepatocellular carcinoma in nude mice]. (2005) (2)
Long-term results of surgery for small primary liver cancer in 514 adults (2005) (2)
Loss of Heterozygosity at D 8 S 298 Is a Predictor for Long-term Survival of Patients withTumor-Node-Metastasis Stage I of Hepatocellular Carcinoma (2007) (2)
Abstract 3003: Immune cell-related microRNA-155 is associated with human liver cirrhosis and hepatocellular carcinoma (2010) (2)
[Effects of the Chinese herbal extract Songyou Yin on the residual hepatocellular carcinoma after chemotherapy in nude mice]. (2013) (2)
The microcell mediated transfer of human chromosome 8 into highly metastatic rat liver cancer cell line C5F. (2003) (2)
Conversion of surgically verified unresectable to resectable hepatocellular carcinoma (1989) (2)
[Immunoprotective effect of IL-2 and B7-1 gene co-transfected liver cancer vaccines on hepatocarcinogenesis in mice]. (2002) (2)
Newsletter – Fall 1998 (1998) (2)
[Changes in the immune function of dendritic cells (DC) derived from HBV-related hepatocellular carcinoma (HCC) patient's peripheral blood monocytes (PBMC) pulsed with tumor antigen]. (2005) (2)
Transfection of thymidine phosphorylase cDNA to human hepatocellular carcinoma cells enhances sensitivity to fluoropyrimidine but augments endothelial cell migration (2005) (2)
[A preliminary study of the killing function in vitro by T lymphocytes activated by dendritic cells loaded with exosomes secreted by hepatic cancer cell lines with high or low metastatic potentials]. (2007) (2)
Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma (2022) (2)
[The value of CA19-9 in diagnosing hepatocellular carcinoma and intrahepatic cholangiocarcinoma]. (2006) (2)
Study on the inhibitory effect of tyroserleutide on tumor growth and metastasis in nude mice model of human hepatocellular carcinoma metastasis. (2007) (2)
Metastasis-related genes in hepatocellular carcinoma cell-lines are clustered on chromosome territories predicted by transcriptome and proteome (2016) (2)
[Diagnosis and management for early hepatic artery thrombosis after liver transplantation]. (2005) (2)
Viral hepatitis (HBV and HCV) background in Chinese patients with hepatocellular carcinoma (1994) (2)
Expert consensus on local ablation therapies for primary liver cancer. (2012) (2)
mRNA levels of nm23 in murine ascites hepatoma (H22) clones with different lymphatic metastatic potential (2005) (2)
[Primary experience of the anatomical laparoscopic left lateral hepatic lobectomy procedure for benign and malignant liver tumors]. (2008) (2)
Treatment of hepatocellular carcinoma: A summary of 33 years' experience (1992) (2)
Multiple Omics Integration Reveals Key Circular RNAs in Hepatocellular Carcinoma (2021) (2)
Corrigendum to "Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma" [J Hepatol 67 (2017) 293-301]. (2017) (2)
Nitric oxide synthase and vascular endothelial growth factor expression in hepatocellular carcinoma and the correlation with angiogenesis (2001) (2)
Thirty years’ studies on surgery and related basic research of hepatocellular carcinoma (2003) (1)
Missing-in-metastasis B (MIM-B) combined with caveolin-1 promotes metastasis of hepatocellular carcinoma (2017) (1)
Multimodality treatment of hepatocellular carcinoma (1998) (1)
[Diagnosis and treatment of primary hepatic carcinoid tumor]. (2007) (1)
Metastasis of Hepatic Cancer (2012) (1)
Modulation of gene expression in MHCC97 cells by interferon alpha. (2005) (1)
[Comparison of the results and therapies for hepatocellular carcinoma with tumor thrombosis in portal vein]. (2003) (1)
[Gene expression profile of human hepatocellular carcinoma cell lines with different metastatic potentials]. (2002) (1)
Erratum to: Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma (2016) (1)
[An in vitro research on interleukin-1 beta promoted invasiveness of human hepatocellular carcinoma MHCC97-H cells]. (2008) (1)
[Time dependency of factors influencing survival of hepatocellular carcinoma patients with portal vein tumor thrombosis after surgery]. (2006) (1)
Reconstruction and expression of chimeric anti-HBx antibody inEscherichia coli (2005) (1)
[Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation]. (2004) (1)
Hepatocellular carcinoma—challenge and prospect in the early 21st century (2004) (1)
Multivariate analysis of risk factors of early and late recurrences after resection for primary clear cell carcinoma of liver (2012) (1)
[Screening hepatocellular carcinoma autoantibodies by serological proteome analysis]. (2005) (1)
Inhibitory effect of huaier on recurrent tumor growth following hepatic resection of hepatocellular carcinoma (2010) (1)
Abstract 5086: The side effects of sorafenib in treating hepatocellular carcinoma. (2013) (1)
[Cryohepatectomy for liver cancer: preliminary evaluation of reducing postoperative recurrence]. (2005) (1)
[Screening low molecular weight protein biomarkers relevant to portal vein tumor thrombi in serum of patients with hepatocellular carcinoma]. (2007) (1)
[Study on the relationship between serum cytokeratin 19 level in hepatocellular carcinoma patients and the clinico-pathologic characteristics]. (2004) (1)
[Quantitative analysis of expression of TEY1 gene in liver cancer cells with different metastatic potential]. (2003) (1)
Imaging , Diagnosis , Prognosis Gene Expression Profiling of Fixed Tissues Identified Hypoxia-Inducible Factor-1 a , VEGF , and Matrix Metalloproteinase-2 as Biomarkers of Lymph Node Metastasis in Hepatocellular Carcinoma (2011) (1)
Tumor recurrence after liver transplantation for hepatocellular carcinoma: prevention and treatment (2011) (1)
Considaration of the role of radiotherapy for intrahepatic cholangiocarcinoma? : A retrospective analysis of 145 patients (2006) (1)
[Migration and invasion of human hepatocellular carcinoma mediated by lung extracts]. (2004) (1)
[Osteopontin promotes the malignant phenotypes of human hepatocellular carcinoma cell line SMMC-7721]. (2007) (1)
Associating liver partition and portal vien ligation for staged hepatectomy (2013) (1)
[Effect of postoperative transcatheter arterial chemoembolization on hepatocellular carcinoma patients with residual tumor]. (2004) (1)
Inhibitory effect of dalteparin sodium on the growth of early-stage hepatocellular carcinoma (2008) (1)
Correction: MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma (2019) (1)
[Therapeutic effectiveness of liver transplantation: a single center study of 203 consecutive cases]. (2005) (1)
[Experimental observation on the alteration of metastatic potential and its gene function net of residual hepatocellular carcinoma following palliative liver resection]. (2010) (1)
My View on the Biological Features and Surgical Treatment of Liver Cancer (2017) (1)
Expression and purification of single-chain anti-HBx antibody in Escherichia coli (1997) (1)
[Clinical research of hepatocellular carcinoma]. (2006) (1)
[Analysis of the risk factors influencing the prognosis of orthotopic liver transplantation for hepatocellular carcinoma and summary of relevant clinical experience]. (2006) (1)
Gene expression in intrahepatic tumors through DNA recombination by a replication-activated adenovirus vector (2004) (1)
Evaluation of Early Detection and Treatment of Hepatocellular Carcinoma (1993) (1)
Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma (2017) (1)
Abstract A21: Expression of placental growth factor in hepatocellular carcinoma and peritumoral liver and its prognostic significance (2010) (0)
Factors influencing the effect of radioimmunotherapy on liver cancer (1992) (0)
Human Cancer Biology Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial – Mesenchymal Transition (2011) (0)
[Quantitation of alpha-fetoprotein messenger RNA in peripheral blood of nude mice and its relationship with tumor recurrence and metastasis after curative resection of hepatocellular carcinoma]. (2002) (0)
The study of AGO1 regulates p53 expression and the prognosis of patients with hepatocellular carcinoma after curative resection (2014) (0)
Abstract 1983: TP53 mutations in hepatocellular carcinoma: Association with survival and stem cell-like gene expression traits (2010) (0)
[The level of transgelin related to the function of dendritic cells pulsed with liver cancer]. (2008) (0)
[Up-regulation of thymidine phosphorylase and anti-angiogenesis by interferon alpha in human hepatocellular carcinoma cell line and xenograft]. (2005) (0)
Consideration of the Role of Radiotherapy for HCC With Portal Vein and/or Inferior Vena Cava Tumor Thrombus: A Retrospective Analysis of 217 Patients (2007) (0)
ASO Visual Abstract: Hepatectomy Following Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy in Patients with Unresectable Hepatocellular Carcinoma (2023) (0)
Strategies for management of unresectable cancer—Introduction (1995) (0)
Microarray analysis of tyroservatide-regulated angiogenesis gene expression profile in human hepatocellular carcinoma cell SMMC-7721 (2008) (0)
An approach improving long-term outcome of surgery for hepatocellular carcinoma: Analysis of 113 patients surviving more than five years (1992) (0)
1101 ANTI-ANGIOGENIC AGENTS MODULATED THE HOST BY SUPPRESSING IL-12b EXPRESSION AND PROMOTED LUNG METASTASIS IN EXPERIMENTAL HEPATOCELLULAR CARCINOMA (2013) (0)
Circulating DNA level of hepatocellular carcinoma and its prognostic value (2006) (0)
Subject Index Vol. 67, 2004 (2005) (0)
Expression and prognostic value of sonic hedgehog in hepatocellular carcinoma (2011) (0)
[Reconstructing the JAK/STATs signal pathway restored the anti-proliferative response of MHCC97 on interferon alpha]. (2006) (0)
The expression of HIF-1α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome (2011) (0)
The predictive value of chromosome 8p deletion for metastasis of hepatocellular carcinoma: a summary of works in 10 years (2008) (0)
[The relationship between lymphangiogenesis and lymphatic metastasis in murine hepatic carcinoma of high and low metastatic potentialities]. (2006) (0)
Promoting invasive ability of hepatocellular carcinoma by co-culture of exosomes from tumor cells with high metastatic potential (2019) (0)
Abstract A25: Array‐based comparative genomic hybridization of hepatocellular carcinoma reveals a unique genomic aberration pattern in tumors with poor prognosis (2009) (0)
Changes of serum alpha fetoprotein before and after radioimmunotherapy in patients with hepatocellular carcinoma (1994) (0)
Relationship between circRNA-100338/microRNA-141-3p axis and phosphatidylinositol 3 kinase/protein kinase B/mammalian target of rapamycin signaling pathway in hepatocellular carcinoma (2019) (0)
[Molecular prediction of metastatic recurrence of hepatocellular carcinoma: from-omics to clinical application]. (2012) (0)
Techniques of anatomical liver resection for hepatocellular carcinoma:a report of 125 cases (2010) (0)
Genetically modified dendritic cells induced specific cytotoxity against human HCC cells in vitro (2004) (0)
CISPLATIN ENHANCE THE ANTITUMOR EFFECT OF HSVTK/GC GENE THERAPY FOR HUMAN HEPATOCELLUALR CARCINONMA (1999) (0)
[Relation between changes of dendritic cell function and down-regulation of beta-centractin in hepatocellular carcinoma]. (2007) (0)
Effects of avastin combined with sorafenib in a highly metastatic murine model of human hepatocellular carcinoma (2010) (0)
Strategies to improve the efficacy of liver transplantation for hepatocellular carcinoma (2011) (0)
Effects of IFN-α on expression of angiogenic factors in highly metastatic human hepatocellular carcinoma cell line HCCLM3 cells (2004) (0)
Results of treatment of primary liver cancer in China (1992) (0)
[A clinicopathologic study of hepatic angiomyolipoma]. (2009) (0)
Vasoinhibitory study of low molecular weight heparins in human hepatocellular carcinoma in nude mice (2004) (0)
Free Paper Session II (2006) (0)
Changes of PAI-1 in plasma and tumor extract of patients with hepatocellular carcinoma (1999) (0)
Effects of interferon-alpha on thymidine phosphorylase expression and apoptosis in human hepatocellular carcinoma SMMC-7721 cells (2009) (0)
Physical Activity Improves Outcomes of Combined Lenvatinib Plus Anti-PD-1 Therapy In Patients With Unresectable Hepatocellular Carcinoma (2021) (0)
Molecular Events on Metastasis of Hepatocellular Carcinoma (2010) (0)
Free Paper Session II (2006) (0)
[Establishment of a high metastatic potential human hepatocellular carcinoma orthotopic transplantation model with palliative liver resection in nude mice]. (2013) (0)
Interaction between missing in metastasis B and caveolin-1 in hepatocellular carcinoma (2017) (0)
[Feasibility of using hepatitis B virus surface antigen as target antigen in immunogen therapy against cancer]. (2002) (0)
The predictive values of combined assessment of preoperative plasma levels of OPN and ICAM-1 for prognosis of patients with hepatocellular carcinoma:retrospective and prospective validations (2006) (0)
Abstract 4818: Validation and clinical utility of a human hepatocellular carcinoma metastasis signature as prognostic classifier (2010) (0)
Re: Technique of Lateral Pancreaticojejunostomy (1998) (0)
[Transcription factor activity profile of human hepatocellular carcinoma cell lines with different metastatic potentials]. (2006) (0)
[Effects of high metastatic potential hepatocellular carcinoma cell-binding peptide on the invasion and metastasis of liver cancer]. (2009) (0)
[Discussion on the road of liver cancer prevention and treatment in China]. (2015) (0)
“Three-Grade Criteria” of radical resection for primary liver cancer (2005) (0)
[Interferon-alpha upregulates thymidine phosphorylase expression via JAK-STAT transcriptional activation and mRNA stabilization in human hepatocellular carcinoma SMMC-7721 cells]. (2008) (0)
[Influence of reconstruction of immunological functions of T lymphocytes on mouse hepatocarcinoma metastasis]. (2005) (0)
Abstract 1556: A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma (2010) (0)
The development and prospects of liver surgery (2023) (0)
̈ Three — Grade Criteria ̈ of RadicaI Resection for (0)
Running title: Serum MDK in Diagnosis of HCC (2013) (0)
[Study of serum proteome biomarkers with relation to the formation of portal vein tumor thrombi in hepatocellular carcinoma patients]. (2005) (0)
Three Decades of Progress in Surgery for Primary Liver Cancer (1997) (0)
Functional localization of metastasis suppressor genes for hepatocellular carcinoma on human chromosome 8p21.1-23.1 (2008) (0)
The effect of phenylacetate on the expansion and cytotoxic activity of adherent lak cells from patients with hepatocellular carcinoma (2002) (0)
Profiling changes in dendritic cells pulsed by hepatocellular carcinomas with different metastatic potentials (2009) (0)
Abstract 4145: Increased anti-tumor effect of sorafenib by depleting tumor associated macrophages (2010) (0)
Abstract LB-408: An integrative genomic approach uncovers oncogenic roles of YY1-signaling in hepatocellular carcinoma with stem cell-like traits (2012) (0)
The roles of loss of heterozygosity at 8p22 in the molecular classification of patients with hepatocellular carcinoma, with special reference to survival after surgical operation (2006) (0)
Important issues of cancer metastasis (2014) (0)
[Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection]. (2005) (0)
[To explore a route to liver cancer research with Chinese features]. (2009) (0)
Effects of exosomal circular RNA-100338 derived from hepatocellular carcinoma on angiogenesis of human umbilical vein endothelial cells (2020) (0)
Molecular and Cellular Pathobiology A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients (2010) (0)
P6-3 CLINICAL EXPERIENCE OF SURGERY FOR HEPATOCELLULAR CARCINOMA (1991) (0)
Free Paper Session IV (2006) (0)
The usefulness of99Tc-PMT delayed hepatobiliary imaging in the diagnosis of small hepatocellular carcinoma (1992) (0)
Abstract 45: The clinical significance of CD163 in patients with hepatocellular carcinoma who underwent curative resection (2012) (0)
[A clinicopathologic study of biliary intraductal papillary neoplasm]. (2010) (0)
Hepatobiliary & Pancreatic Diseases International. (2017) (0)
The role of TMPRSS4 in radiation induced metastasis of hepatocellular carcinoma (2011) (0)
[Changes of metastatic potential of residual hepatocellular carcinoma in nude mice after in vivo chemotherapy and the corresponding mechanisms]. (2012) (0)
Prognostic Subtypes of Hepatocellular Carcinoma-Fetoprotein Expression Defines Novel α EpCAM and Updated (2008) (0)
[Interferon alpha enhances the sensitivity of SMMC-7721 hepatocellular carcinoma cells to 5'-deoxy-5-fluorouridine related to up-regulation of thymidine phosphorylase]. (2007) (0)
[Key issues and prospects for the study on metastasis of hepatocellular carcinoma]. (2008) (0)
[Functional localization of metastasis suppressor genes for HCC on human chromosome 8]. (2008) (0)
Cancer Metastasis: Metastasis of Primary Liver Cancer (2011) (0)
Using the miR-26 family as a predictive marker of hepatocellular carcinoma and sensitivity to therapy (2009) (0)
Urokinase-type plasminogen activator, its receptor and inhibitor expression in hepatocellular carcinoma relation to cancer invasiveness and prognosis (1998) (0)
Contents Vol. 67, 2004 (2005) (0)
The mechanism of pseudomonasaeruginosa mannose sensitive hamemagglutination vaccine in inducing apoptosis of hepatocellular carcinoma (2011) (0)
[The investigation of the technology of microcell mediated chromosome transfer for functional localization of metastasis suppressor genes for liver cancer on human chromosomes]. (2006) (0)
[Segmentectomy for hepatoma originated from segment IX]. (2004) (0)
Follow-up study in 20-year survivors after resection for hepatocellular carcinoma in 53 cases (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Zhao‐you Tang?

Zhao‐you Tang is affiliated with the following schools:

Fudan University